below the procedure described in this invention is illustrated by the following example which is not limiting the applicability and the scope of the invention : normal whole blood was obtained from healthy volunteers after informed consent . for each test , 100 μl of whole blood from an edta vacutainer tube ( bd ) was added to a bead product for absolute counting in cytometry such as a tube containing a known number of beads sold under the trade names t ru count ( bd biosciences ), f low count ( beckmann / coulter hialeth , fla .) or p erfect count beads ( cytognos , salamanca , spain ). to this sample tube , 5 μl of anti - hla - dr - fitc reagent , 5 μl of anti - cd33 - pe reagent , 5 μl of anti - cd45 - percp - cy5 . 5 reagent and 5 μl of anti - cd14 - apc reagent ( bd biosciences ) were added and gently mixed for 5 seconds . this reagent / sample mixture was incubated for 15 minutes in the dark at room temperature . subsequently 2 ml of facs lysing solution ( bd biosciences ), diluted 1 : 10 with distilled water , were added . this new reagent / sample mixture was gently mixed for 5 seconds and incubated for another 15 minutes in the dark at room temperature . the reagent / sample mixture was kept in the dark until they were run on a dual laser facscalibur brand flow cytometer . the stained cells should be analyzed within two hours following the addition of the facs lysing solution . the sample data were recorded and analyzed on a g4 macintosh computer equipped with cellquest pro software for a total of 60 , 000 events per sample . during acquisition information was recorded after thresholding for those events which showed positivity for cd45 and / or hladr and / or had high forward light scatter ( fsc ) values , in order to restrict data acquisition to leukocytes and nucleated cells and to eliminate most of the events corresponding to non - nucleated red cells , platelets and debries . in fig1 the sequence used for data analysis is illustrated by up to thirteen different representative bivariate dot plots ( or scattergrams ), for a normal peripheral lysed whole blood sample . in dot plots ( a ), ( b ) and ( c ) all events acquired are displayed . in order to specifically select the nucleated cells and the beads present among all events regions were set as to include those events with intermediate / high fsc ( region 1 in plot a ) and / or positivity for cd45 ( region 2 in plot b ) and / or positivity for hladr ( region 3 in plot c ), independently of their sideward light scatter values . r4 in plot b identifies the reference beads ( gate 1 , see below ): plot ( a ) is a scattergram of fsc versus orthogonal light scatter ( ssc ). all events acquired are shown and a region called out as region 1 or r1 is selected to identify the largest cells . plot b is a bivariate histogram of ssc versus anti - cd45 - percp - cy5 . 5 fluorescence . all events acquired are shown and a gate , called out as region 2 or r2 , is selected to separate the non - nucleated red cells , platelets and cell debris at the lower right end of the display from the leukocyte populations on the right hand side of the gate . r4 drawn in this dot plot identifies the bead population . plot c is a scattergram of orthogonal light scatter ( ssc ) versus anti - hla - dr - fitc fluorescence . all events are shown and a third gate , called out as region 3 or r3 , is selected to separate the large cluster of cells on the left hand side of the display together with some low scatter , low fluorescence expression from the cell populations on the lower right hand side of the display . to proceed with the cell selection and enumeration , an electronic ‘ gate ’ ( gx ) will be defined that can contain logical combinations of the identified regions under the logical functions ‘ and ’, ‘ or ’ and ‘ and not ’. if a gate defines a ‘ and ’ function between regions , all events summed in the gate ( gx ) will be events that belong to region rx and region ry . if a gate defines a ‘ or ’ function between regions , all events summed in the gate ( gx ) will be events that belong to region rx or to region ry . if a gate defines a ‘ and not ’ function between regions , all events summed in the gate ( gx ) will be events that belong to region rx and not to region ry . gate 1 or g1 includes those events include in region 4 or r4 and corresponds to the counting beads . a fourth scattergram ( d ) is generated , identical to ( b ), with orthogonal light scatter versus anti - cd45 - percp - cy5 . 5 fluorescence except for the fact that in this bivariate dot plot only those events corresponding to the nucleated cells — events included in gate 2 or g2 =( not r4 and r1 and / or r2 and / or r3 )— are shown . using these definitions , in a normal peripheral blood the nucleated cells will represent the total leukocyte concentration which in the sample can therefore be found under gate 2 ( g2 ). in this fourth bivariate dot plot three major distinct groups of events are identified called out as region 5 ( or r5 ), region 6 ( or r6 ) and region 7 ( or r7 ). r5 defines the large middle population of events and r6 defines the population at the upper end of the scattergram containing events having very large orthogonal scatter values . r7 groups the events at the lower right end of the scattergram and bundles several clusters of events that will require further separation in the subsequent steps . by further using the ‘ gate ’ tool as defined above , we can define specific leukocyte subsets which are included within these three regions : r5 to r7 , both included . plot e shows a bivariate scattergram of anti - cd14 - apc versus anti - hla - dr - fitc fluorescence for those events included in r5 . within this scattergram ( plot e ) two regions ( r8 and r9 ) are defined : one ( r8 ) to the left of the center of the scattergram and the other just to the right of r8 ( r9 ), as shown in fig1 . plot f shows a fsc versus cd33 - pe bivariate scattergram and plot g an hladr - fitc versus cd33 - pe dot plot histogram ; in these plots ( f and g ) two regions ( r10 and r11 ) are defined as depicted in fig1 : one ( r10 in plot f ) includes cd33 - pe dim / intermediate positive events with intermediate to high fsc values while the other region ( r11 in plot g ) includes autofluorescent events which cluster as hladr - fitc negative and cd33 dimly positive cells . using the ‘ gate ’ tool as defined above , we can define specific leukocyte subsets which are included within the following sets of three regions : neutrophils ( g3 = g2 and r5 and r8 and r10 ) and eosinophils ( g4 = g2 and r6 and r9 and r11 ). plot ( h ) shows a scattergram of anti - cd14 - apc fluorescence versus anti - cd33 - pe fluorescence . a region 12 ( r12 ) can be defined to enclose the cell cluster to the top right close to the center of the scattergram . define gate 5 ( g5 ) as the logical combination of gate 2 and region 7 and region 12 — g5 = g2 and r7 and r12 -. gate 5 — g5 — defines the concentration of the monocytes . plot ( i ) shows a scattergram of anti - cd33 - pe fluorescence versus anti - hla - dr - fitc fluorescence . region 13 can be drawn to enclose the cluster of the cells to the middle of the left hand side of the scattergram ( cd33 - pe positive , hladr - fitc negative ). plot ( j ) shows a scattergram of orthogonal light scatter versus anti - cd45 - percp - cy5 . 5 fluorescence . region 14 ( r14 ) can be drawn here to enclose the cluster of events to the middle lower part of the display ( low ssc and cd45 positive dim ). define gate 6 ( g6 ) as the logical combination of gate 2 and region 7 and region13 and region14 and not region 12 and not gate 3 and not gate 4 and not gate 5 ( g6 = g1 and r7 and r13 and r14 and not r12 and not g3 and not gate 4 ). g6 defines the concentration of the basophils . plot ( k ) shows a scattergram of orthogonal light scatter versus anti - hla - dr - fitc fluorescence . draw the region 15 ( r15 ) to enclose the population of events along the top of the horizontally extended population with low ssc . plot ( l ) shows a scattergram of orthogonal light scatter ( ssc ) versus forward light scatter ( fsc ). define region 16 ( r16 ) to enclose the cluster of events along the x - axis with low orthogonal light scatter ( ssc ) values . define gate 7 ( g7 ) as the logical combination of gate 2 and region 7 and region 16 and not gate 3 and not gate 4 and not gate 5 and not gate 6 ( g7 = g2 and r7 and r16 and not g3 and not g4 and not g5 and not g6 ). gate 7 — g7 — defines the concentration of lymphocytes . define gate 8 ( g8 ) as the logical combination of gate 2 and region 7 and region 15 and not gate 3 and not gate 4 and not gate 5 and not gate 6 and not gate 7 ( g8 = g2 and r7 and r15 and not g3 and not g4 and not g5 and not g6 and not g7 ). plot ( m ) shows a scattergram of anti - cd33 - pe versus anti - cd45 - percp - cy5 . 5 fluorescence only for those events included in gate 8 ( g8 ). draw region 17 ( r17 ), region 18 ( r18 ) and region 19 ( r19 ). define gate 9 ( g9 ) as the logical combination of gate 8 and region 17 ( g9 = g8 and r17 ). this gate 9 — g9 — defines the concentration of the lymphoplasmacytoid dendritic cells . define gate 10 ( g10 ) as the logical combination of gate 8 ( g8 ) and region 18 . gate 10 — g10 — defines the concentration of the cd16 + dendritic cells / monocytes . define gate 11 ( g11 ) as the logical combination of gate 8 ( g8 ) and region 19 ( r19 ). gate 11 — g11 — defines the concentration of cd33 + hi myeloid dendritic cells . define gate 12 ( g12 ) as those events falling in gate 9 ( g9 ) or gate 10 ( g10 ) or gate 11 ( g11 ). gate 12 — g12 — defines the total concentration of the dendritic cells . as result of the different and sequential analysis steps , up to ten ( including sub - segmentation of the dendritic cell population ) leukocyte subpopulations can be defined and enumerated in a normal peripheral blood sample . using the bead count under the defined reagent / sample mixture , a concentration parameter can be calculated in terms of cells per microliter . this expression of results will allow a direct correlation with the hematology counters installed routinely in the clinical laboratories . the enumerated and defined subpopulations have very well defined positioning characteristics in the different scattergrams . this is due to their specific fluorescence intensity labeling with the help of the monoclonal antibodies used . the analysis of a series of samples of healthy volunteers shows that each of the identified leukocyte subpopulations can be characterized in terms of coordinate positions of their gravity center along the x - and the y - axis for each bivariate dot plot . in addition , each of the subpopulations identified has characteristic limits of spread of the population distribution ( cv ). both of these parameters ( gravity position , spread ) are included in the identification of the subpopulations . the specific spacing found between each of the above listed normal peripheral blood subpopulations in the 6 - multidimensional space created with the measurement creates the necessary space for any abnormal cell populations to show as a separate and non regular leukocyte cell cluster . specific diseases result in a specific fingerprint on the scattergram with cell clusters in the non regular cell spaces . based on these non regular cell clusters , disease states can be diagnosed and monitored . this can be achieved both in ex vivo obtained samples and in vitro manipulated cell samples obtained for any research , diagnostic and / or prognostic purposes . all publications and patent applications mentioned in this specification are indicative of the level of ordinary skill in the art to which this invention pertains . all publications and patent applications are herein incorporated by reference to the same extent as if each individual publication or patent application was specifically and individually indicated to be incorporated by reference . it will be apparent to one of ordinary skill in the art that many changes and modifications can be made in the invention without departing from the spirit or scope of the appended claims .